SPOTLIGHT -
Consumer focus is an enterprisewide strategy
The Durability of Roctavian and the Need for Corticosteroids
Data from clinical trials suggest that the vast majority of the patients respond to the gene therapy for hemophilia A, says Courtney Thornburg, M.D., M.S. But there is also decreasing factor expression.
Read More
Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organization's Trajectory, More
Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position that same month.
Listen
Nearly 2 in 3 telehealth visits involve behavioral health
Patients are choosing virtual care for mental health needs. But telehealth usage in other areas has dropped, suggesting some patients prefer office visits.
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Chances of Developing Gout Are Higher for Patients With IBD
Study links inflammatory bowel disease diagnosis to increased gout risk, with Crohns disease and ulcerative colitis linked to 68% and 38% increases in likelihood of developing gout, respectively, relative to counterparts without IBD.
Roflumilast Cream Meets Endpoint in Study of Young Children with Atopic Dermatitis
In addition, a supplemental new drug application has been filed for roflumilast cream .15% to treat mild-to-moderate atopic dermatitis in adults and children aged 6 years and older.
